No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
NANO MRNA Co., Ltd. specializes in the discovery, advancement, and manufacturing of pharmaceutical products, employing its innovative micellar nanoparticle platform. Its biopharmaceutical pipeline is primarily geared towards addressing oncological conditions and a range of other severe illnesses. The enterprise also undertakes the full spectrum of activities for anti-cancer medications, from initial scientific investigation to market commercialization, all underpinned by its distinctive micellar nanoparticle approach. Established on June 14, 1996, by Kazunori Kataoka, Teruo Okano, and Ichiro Nakatomi, the firm maintains its principal operations in Tokyo, Japan.
www.nanomrna.co.jpNo one on the platform currently holds 4571.T.
No tracked institution reports a position in 4571.T as of their last filing.
No one on the platform has traded 4571.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 4571.TNANO MRNA Co.,Ltd. | $98.00 | -2.97% | $8.2B | — |
| 2183.TLinical Co., Ltd. | $203.00 | -0.49% | $4.6B | — |
| 2370.TMEDINET Co., Ltd. | $24.00 | +0.00% | $6.7B | — |
| 3544.TSatudora Holdings Co.,Ltd. | $1249.00 | +0.00% | $17.2B | — |
| 4579.TRaQualia Pharma Inc. | $568.00 | +1.43% | $13.9B | — |
| 4583.TChiome Bioscience Inc. | $88.00 | +1.15% | $6.4B | — |
| 4584.TKidswell Bio Corporation | $165.00 | +0.00% | $8.2B | — |
Source: Financial Modeling Prep · peers by sector/industry